The overall objective of the program is to train clinicians from surgical oncology specialties to develop skills and expertise in basic science and translational research. The surgery disciplines at Roswell Park Cancer Institute (RPCI) have approved clinical training programs in general surgical oncology, urologic oncology and gynecologic oncology and have trained a number of fellows that are currently in academic positions. The proposed laboratory research program will enhance these efforts and provide the training necessary for these fellows to develop their research expertise skills central to academic development in surgical oncology. After completion of their clinical rotations, trainees will enter into two years of full-time laboratory cancer research in one of 5 areas of scientific study: 1) molecular &cellular biology, 2) immunology 3) genetics, 4) pharmacology &experimental therapeutics, or 5) cancer prevention &epidemiology. During two-years of protected time, trainees will work under the mentorship of selected faculty from one of these areas. Preceptors from a variety of disciplines have been selected based on extensive experience in training young investigators. An administrative committee will monitor the trainee's progress as well as the preceptor's activities and the overall program direction including assessment of minority recruitment. Trainees will also attend a multidisciplinary course in Oncology that involves lectures in basic science as well as in areas of medical, surgical and radiation oncology. In addition, trainees will be formally educated in biostatistics and the ethical principles of research. It is our goal to provide training and expertise toward the development of strong basic and translational scientific research skills that will enable trainees to assume productive academic positions in these respective surgical oncology specialties. Thus, the administrative team, the preceptors and the RPCI research environment all provide an outstanding forum for further interaction, education, and training and collaborative research activities for these trainees.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA108456-05
Application #
7920015
Study Section
Subcommittee G - Education (NCI)
Program Officer
Lim, Susan E
Project Start
2006-09-01
Project End
2011-08-31
Budget Start
2010-09-01
Budget End
2011-08-31
Support Year
5
Fiscal Year
2010
Total Cost
$232,996
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
824771034
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Kesterson, Joshua P; Szender, J Brian; Schaefer, Eric et al. (2018) Evaluation of Association Between Gynecologic Oncology Fellowship Length and a Career in Academic Medicine. J Cancer Educ 33:141-146
Mayor, Paul C; Eng, Kevin H; Singel, Kelly L et al. (2018) Cancer in primary immunodeficiency diseases: Cancer incidence in the United States Immune Deficiency Network Registry. J Allergy Clin Immunol 141:1028-1035
Mark, Jaron; Morrell, Kayla; Eng, Kevin et al. (2018) Expert Review of Cervical Cytology: Does it Affect Patient Care? J Low Genit Tract Dis 22:120-122
Eng, Kevin H; Szender, J Brian; Etter, John Lewis et al. (2018) Paternal lineage early onset hereditary ovarian cancers: A Familial Ovarian Cancer Registry study. PLoS Genet 14:e1007194
Minlikeeva, Albina N; Moysich, Kirsten B; Mayor, Paul C et al. (2018) Anthropometric characteristics and ovarian cancer risk and survival. Cancer Causes Control 29:201-212
Szender, J Brian; Kaur, Jasmine; Clayback, Katherine et al. (2018) Breadth of Genetic Testing Selected by Patients at Risk of Hereditary Breast and Ovarian Cancer. Int J Gynecol Cancer 28:26-33
Mayor, Paul; Starbuck, Kristen; Zsiros, Emese (2018) Adoptive cell transfer using autologous tumor infiltrating lymphocytes in gynecologic malignancies. Gynecol Oncol 150:361-369
Cannioto, Rikki; Etter, John Lewis; Guterman, Lauren Beryl et al. (2017) The association of lifetime physical inactivity with bladder and renal cancer risk: A hospital-based case-control analysis. Cancer Epidemiol 49:24-29
Szender, J Brian; Papanicolau-Sengos, Antonios; Eng, Kevin H et al. (2017) NY-ESO-1 expression predicts an aggressive phenotype of ovarian cancer. Gynecol Oncol 145:420-425
Cresci, Gail A M; Mayor, Paul C; Thompson, Stuart A (2017) Effect of butyrate and Lactobacillus GG on a butyrate receptor and transporter during Campylobacter jejuni exposure. FEMS Microbiol Lett 364:

Showing the most recent 10 out of 79 publications